Pain Relief During IUD Insertion in Women Delivered Only by Elective Cesarean Section (NCT03587077) | Clinical Trial Compass
UnknownNot Applicable
Pain Relief During IUD Insertion in Women Delivered Only by Elective Cesarean Section
113 participantsStarted 2018-09
Plain-language summary
The aim of the work is to assess the effect of combined misoprostol 200 mcg and isosorbide mononitrate 40 mg versus misoprostol 200 mcg and placebo as local vaginal tablet on the successful IUD insertion.
Who can participate
Age range18 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:We will include
* Nonpregnant women,
* aged 18-45 years, .delivered before only by elective CS and did not receive any analgesics in the 24 h prior to IUD insertion.
Exclusion Criteria:We will exclude
* Women with any uterine abnormalities as congenital anomalies,
* Women with endometrial lesions,
* Women with adenomyosis,
* Women with fibroids,
* Women with intrauterine adhesions,
* Women with chronic pelvic pain,
* Women with spasmodic dysmenorrhea,
* Women with abnormal uterine bleeding,
* Women with history of cervical surgery, .Women with allergy to misoprostol or isosorbide mononitrate or any medical disease that contraindicates its use and those who refused to participate in the study.